Skip to content

Towards a Health Promotion for Children Engaged in Sport Intensive Practice for a Healthy Adult

Towards a Health Promotion for Children Engaged in Sport Intensive Practice for a Healthy Adult

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06645574
Acronym
PROTEGE
Enrollment
90
Registered
2024-10-17
Start date
2025-09-30
Completion date
2032-12-31
Last updated
2025-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention

Brief summary

This project aims to elucidate the complexities of the preventive approach among young people involved in intensive sports activities, providing valuable recommendations to optimize their physical, mental, and social health both in the present and in the long term. The multidisciplinary skills of a team of researchers in sports science and health will contribute their recognized disciplinary expertise through international publications, as well as solid experience in the demands of elite sports, along with a commitment to transferring innovative knowledge toward a preventive approach to sports training. The main objective is to determine whether a somatotype aligned with the discipline's expectations protects the athlete in terms of self-perception and, consequently, reduces health-risk behaviors. Secondary objectives will include linking somatotype, growth, psychological changes (self-perception), and the emergence of health-risk behaviors or injuries in these young athletes.

Interventions

OTHERThe multidisciplinary preventive approach among young people involved in intensive sports activities. Athlete will see doctor and physiotherapist.

Athletes will have 2 times per years prevention examination: * A standard medical examination * A physiotherapy assessment with strength assessment * They will complete psychometric evaluation self-questionnaires

Sponsors

Fondation Lenval
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Years to 15 Years
Healthy volunteers
Yes

Inclusion criteria

* Children aged 8 to 15 years old * Intensive athletes: that is to say they practice a competitive sporting activity with a number of hours of weekly training greater than their age in years.(For example, a 10 year old child will need to train more than 10 hours per week to be included.) * Sport at an early age * Obtaining written and signed informed consent from one of the two parents or the holder of parental authority * Affiliation to a social security system

Exclusion criteria

menstruation for more than a year at the time of inclusion \-

Design outcomes

Primary

MeasureTime frameDescription
Determine whether a somatotype in harmony with the expectations of the discipline protects the athlete in terms of self-perceptions and, consequently, reduces risky behaviors for her health.2 times a year for up to 84 months of follow-upfrequency of occurrence of risky behavior depending on the somatotype of the athletes

Secondary

MeasureTime frameDescription
1. How does the somatotype of athletes change over time and in response to training? Are these modifications uniform among athletes of the same sex practicing the same sport?2 times a year for up to 84 months of follow-upThe evolution of the somatotype of athletes over time and in response to training Relationship between athlete somatotype and growth acceleration at puberty Self-esteem and perception of physical appearance between athletes conforming and nonconforming to the ideal somatotype of their sport The prevalence of ACAD and excessive training practices among athletes with low self-esteem related to their physical appearance. Correlation between athletes' somatotype and their predisposition to health problems, such as eating disorders and sports injuries

Contacts

Primary ContactVirginie RAMPAL, PhD
virginie.rampal@hpu.lenval.com0033 4 92 03 05 41

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026